Inflammatory Breast Cancer and Warm Antibody Autoimmune Hemolytic Anemia: A Rare Paraneoplastic Syndrome

Autoimmune hemolytic anemia (AIHA) is a disease process that involves the destruction of red blood cells mediated by the humoral immune system. It can be characterized as a cold agglutinin syndrome, paroxysmal cold hemoglobinuria, and warm, mixed type, and drug-induced AIHA. Although a well-established relationship exists between the presence of AIHA and lymphoproliferative malignancy, AIHA rarely presents in association with solid malignancies. An analysis of the limited number of published cases of AIHA in association with solid malignancies performed showed that AIHA may present before the diagnosis of a solid malignancy, concurrently with the presence of a solid malignancy, or even on resolution of a solid malignancy. Few cases of solid cancers associated with AIHA have been reported. AIHA rarely presents as a paraneoplastic syndrome indicating existence of a solid cancer. We report a case of inflammatory breast cancer with AIHA.

[1]  B. Berman,et al.  Immune Hemolytic Anemia (Paroxysmal Cold Hemoglobinuria) Preceding Burkitt Lymphoma in a 12-Year-Old Child. , 2017, Journal of pediatric hematology/oncology.

[2]  E. Beleva,et al.  Autoimmune Phenomena in Patients with Solid Tumors , 2016, Folia medica.

[3]  Yi-qun Huang,et al.  [Rituximab plus Autologous Hemotopoietic Stem Cell Transplantation for The Treatment of CD5 Positive Diffuse Large B Cell Lymphoma with Autoimmune Hemolytic Anemia]. , 2016, Zhongguo shi yan xue ye xue za zhi.

[4]  Yuan Yu,et al.  Pure Red Cell Aplasia and Autoimmune Hemolytic Anemia Sequentially Occurring in a Patient with Large Granular T-lymphocytic Leukemia. , 2016, Internal medicine.

[5]  T. Kamesaki [Autoimmune hemolytic anemia as a paraneoplastic syndrome associated with solid tumors]. , 2015, [Rinsho ketsueki] The Japanese journal of clinical hematology.

[6]  K. Loh,et al.  Paraneoplastic Autoimmune Hemolytic Anemia in Ovarian Cancer: A Marker of Disease Activity , 2015, Rare tumors.

[7]  G. Hortobagyi,et al.  Long-term treatment efficacy in primary inflammatory breast cancer by hormonal receptor- and HER2-defined subtypes. , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

[8]  F. Robertson,et al.  A global approach to inflammatory breast cancer. , 2011, Future oncology.

[9]  K. Lechner,et al.  Autoimmune hemolytic anemia as a paraneoplastic phenomenon in solid tumors: A critical analysis of 52 cases reported in the literature , 2010, Wiener klinische Wochenschrift.

[10]  H. Altermatt,et al.  AUTOIMMUNPROZESSE ALS PARANEOPLASTISCHE MANIFESTATIONEN BEI FAMILIAREM MAMMAKARZINOM , 2008 .

[11]  R. Stamps,et al.  Erythrocyte autoantibodies, autoimmune haemolysis, and carcinoma. , 1994, Journal of clinical pathology.

[12]  A. Calderoni,et al.  [Autoimmune processes as paraneoplastic manifestations in familial breast carcinoma]. , 1994, Deutsche Medizinische Wochenschrift.

[13]  G. Papa,et al.  A Metastatic Breast Carcinoma Presenting as Autoimmune Hemolytic Anemia , 1991, Tumori.

[14]  M. Slevin,et al.  Autoimmune haemolytic anaemia associated with malignant peritoneal mesothelioma. , 1989, Acta Clinica Belgica.